Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
September 28, 2026 by regulatorwatch.com
Decisive Move | Haypp Goes All-In on U.S. Nicotine Pouch Market | RegWatch
Haypp’s move into the US nicotine pouch market reflects more than business expansion. It signals growing consumer demand for smoke-free products that are convenient, discreet and separate from combustion. That shift matters because markets can either be shaped through responsible standards or left to develop without enough oversight. A strong harm reduction framework should make room for adult access, product accountability and clear information about where pouches sit on the risk spectrum.
September 25, 2026 by wsj.com
U.S. Regulators Plan Major Move to Speed Authorizations of Vapes, Tobacco Pouches
A faster FDA pathway for vapes and nicotine pouches would matter most for the legal market. Years of slow authorisations have left adult smokers with limited approved options while illicit and unapproved products fill the gap. Speed should not mean weak standards; it should mean timely, evidence-based decisions that distinguish responsible smoke-free products from those that fail basic tests. Harm reduction needs regulation that can move quickly enough to keep safer alternatives inside accountable channels.
September 24, 2026 by substack.com
Teen Vaping Is Falling in Pennsylvania...so why does the state still say it is skyrocketing
Pennsylvania’s teen vaping trend tells a less dramatic story than many policy campaigns suggest. Youth use is falling, yet the political response often remains locked in crisis mode, with restrictions aimed at a problem that may already be moving in the right direction. That matters because outdated alarm can distort priorities and spill over onto adults who smoke. Prevention should follow the data, not preserve a panic after the trend has changed.
September 24, 2026 by substack.com
Knowledge is Power
Knowledge is power in tobacco harm reduction because it gives smokers something more useful than fear. Understanding combustion, nicotine, relative risk and switching can change the choices people believe are available to them. Poor information keeps cigarettes protected by confusion, while clear information helps adults see a route away from the most harmful product. Public health should not be afraid of informed consumers; it should depend on them.
September 23, 2026 by substack.com
Knowledge is Power
Knowledge is power in tobacco harm reduction because it gives smokers something more useful than fear. Understanding combustion, nicotine, relative risk and switching can change the choices people believe are available to them. Poor information keeps cigarettes protected by confusion, while clear information helps adults see a route away from the most harmful product. Public health should not be afraid of informed consumers; it should depend on them.
September 23, 2026 by 2firsts.com
Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.
September 23, 2026 by 2firsts.com
Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
A nicotine substitute entering the market before key human evidence is available should make regulators ask better questions, not reach for easy assumptions. New molecules such as 6-methyl nicotine may sit outside familiar tobacco and nicotine frameworks, but that does not make them automatically safer, riskier or irrelevant. The priority should be transparent testing, pharmacology, exposure data and real-world monitoring before public health claims are made. Innovation can support harm reduction only when the evidence keeps pace with the product.
September 22, 2026 by reason.org
Youth vaping has collapsed, but lawmakers want $500 million to fight it anyway
Half a billion dollars to fight a collapsing trend deserves scrutiny. Youth vaping has fallen sharply, yet lawmakers are still treating it as an expanding emergency while adult smoking remains the bigger driver of preventable disease. Resources should follow the scale of harm, not the politics of alarm. Serious nicotine policy would protect young people without using outdated crisis language to justify measures that may also make quitting harder for adults.
September 22, 2026 by thejournal.ie
FactFind: Are vapes 'nearly worse' than cigarettes?
The phrase “vaping is worse than smoking” does more than misstate the evidence — it changes behaviour. A smoker who believes that message may see little reason to switch, even though cigarettes remain the far more harmful product. Good fact-checking restores the missing hierarchy: vaping is not harmless, but it is not smoking. Clear risk communication can be the difference between staying with combustion and taking a less harmful route away from it.
September 21, 2026 by regulatorwatch.com
Science Inside | NicoLeaks Supercharges Nicotine Pouch Testing | RegWatch
Nicotine pouch testing should be driven by science, not suspicion by category. Better data on ingredients, emissions, exposure and product performance can help regulators distinguish between responsible smoke-free products and those that fail basic standards. That matters because credible harm reduction depends on transparency as much as access. The stronger the testing framework, the harder it becomes to dismiss pouches with fear — or to defend products that do not meet the evidence.
- Page 1 of 168